Free tool
FAERS Monitor: Bumex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018225 or its brand name (Bumex, Bumetanide). Reports on generic versions are filed under their own applications.
Reports
26,832
Serious
20,610
77% of reports
Hospitalization
12,865
Death reported
4,181
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea2,720
- fatigue1,780
- death1,731
- acute kidney injury1,711
- diarrhoea1,628
- nausea1,585
- dizziness1,330
- headache1,301
- pneumonia1,152
- renal failure1,142
- asthenia1,101
- hypotension1,081
- pain1,071
- fall980
- cardiac failure congestive979
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 298 |
| 2005 | 377 |
| 2006 | 366 |
| 2007 | 315 |
| 2008 | 334 |
| 2009 | 411 |
| 2010 | 550 |
| 2011 | 677 |
| 2012 | 719 |
| 2013 | 749 |
| 2014 | 992 |
| 2015 | 1,302 |
| 2016 | 1,653 |
| 2017 | 1,658 |
| 2018 | 1,859 |
| 2019 | 1,944 |
| 2020 | 1,960 |
| 2021 | 1,443 |
| 2022 | 1,357 |
| 2023 | 1,728 |
| 2024 | 2,157 |
| 2025 | 2,268 |
| 2026 | 1,714 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,327 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| cardiac failure congestiveSignal | 979 | 9.7 | 9.1 | 7,526 |
| acute kidney injurySignal | 1,711 | 8.9 | 8.5 | 11,862 |
| renal failureSignal | 1,142 | 6.8 | 6.4 | 5,621 |
| hypotensionSignal | 1,081 | 4.2 | 4.0 | 2,686 |
| dyspnoeaSignal | 2,720 | 3.8 | 3.6 | 5,684 |
| pneumoniaSignal | 1,152 | 2.8 | 2.6 | 1,343 |
| fallSignal | 980 | 2.3 | 2.2 | 738 |
| astheniaSignal | 1,101 | 2.3 | 2.2 | 819 |
| dizzinessSignal | 1,330 | 2.1 | 2.0 | 775 |
| diarrhoea | 1,628 | 2.0 | 1.9 | 811 |
| fatigue | 1,780 | 1.8 | 1.7 | 647 |
| headache | 1,301 | 1.6 | 1.5 | 323 |
| death | 1,731 | 1.6 | 1.5 | 379 |
| nausea | 1,585 | 1.6 | 1.5 | 340 |
| pain | 1,071 | 1.4 | 1.3 | 108 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.